INS and Hypoglycemia: Medication adherence also remains suboptimal (53% for α-glucosidase inhibitors, 55% for biguanides, 61% for Sodium-Glucose Cotransporter 2 Enzyme Inhibitors and insulin secretagogues), often due to side effects such as hypoglycemia and gastrointestinal discomfort [90].